Ovarian clear cell carcinoma (OCCC) represents a rare and aggressive subtype of epithelial ovarian cancer with distinctive clinical and molecular characteristics. However, the identification, origin, and molecular features of the malignant epithelial cells in OCCC remain poorly studied. We establish an OCCC-associated transcriptional landscape using single-cell RNA sequencing and investigated the properties of epithelial cells in tissues from normal ovaries, ovarian endometriosis, primary OCCC and recurrent OCCC to assess the status of malignant epithelial cells. We identify a specific subcluster of malignant epithelial cells and further analyze them to discover 173 candidate factors associated with OCCC. Regulon and pseudotime trajectory analyses reveal six transcription factors (TFs) and their corresponding targets among these candidate factors, highlighting their roles in OCCC onset and reoccurrence. Through experimental validation, we confirm the crucial involvement of STAT3, KLF5, and TRIM28 in the proliferation and migration of OVISE cells. Silencing these three TFs also results in the down-regulation of their associated TF targets linked to OCCC. Overall, we characterize complex malignant-like cell populations at single-cell resolution and highlighted several TFs and their targets, providing essential resources for understanding the regulatory mechanisms underlying OCCC initiation and recurrence.
Epithelial characteristics of ovarian clear cell carcinoma at single-cell resolution.
单细胞分辨率下卵巢透明细胞癌的上皮特征
阅读:15
作者:Guo Qinhao, Chen Xia, Bi Rui, Li Haiming, Liu Meng, Ju Xingzhu, Feng Zheng, Zhu Jun, Li Yizhen, Wang Xin, Huang Qiuru, Li Jiaxin, Zhou Xiaonan, Zheng Ying, Zheng Bo, Wu Xiaohua, Yu Jun, Wen Hao
| 期刊: | Communications Biology | 影响因子: | 5.100 |
| 时间: | 2025 | 起止号: | 2025 Aug 5; 8(1):1156 |
| doi: | 10.1038/s42003-025-08617-4 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
